Drug name - Olinvyk
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8835488 | TREVENA | Opioid receptor ligands and methods of using and making same |
Mar, 2032
(9 years from now) | |
| US9309234 | TREVENA | Opioid receptor ligands and methods of using and making same |
Mar, 2032
(9 years from now) | |
| US11077098 | TREVENA | Opioid receptor ligands and methods of using and making same |
Mar, 2032
(9 years from now) | |
| CN103702561B | TREVENA | Opioid Receptor Ligands And Methods Of Using And Preparing Method Thereof |
Mar, 2032
(9 years from now) | |
| CN103702561A | TREVENA | Opioid Receptor Ligand, And Use And Preparation Method Thereof |
Mar, 2032
(9 years from now) | |
| IN324754B | TREVENA | An Opioid Receptor Compound |
Mar, 2032
(9 years from now) | |
| IN201308346P1 | TREVENA | Opioid Receptor Ligands And Methods Of Using And Making Same |
Mar, 2032
(9 years from now) | |
| EP3290415A1 | TREVENA | Opioid Receptor Ligands And Methods Of Using And Making Same |
Mar, 2032
(9 years from now) | |
| EP2688403A1 | TREVENA | Opioid Receptor Ligands And Methods Of Using And Making Same |
Mar, 2032
(9 years from now) | |
| EP2688403A4 | TREVENA | Opioid Receptor Ligands And Methods Of Using And Making Same |
Mar, 2032
(9 years from now) | |
| EP2688403B1 | TREVENA | Opioid Receptor Ligands And Methods Of Using And Making Same |
Mar, 2032
(9 years from now) | |
| EP3290415B1 | TREVENA | Opioid Receptor Ligands And Methods Of Using And Making Same |
Mar, 2032
(9 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9642842 | TREVENA | Opioid receptor ligands and methods of using and making same |
Mar, 2032
(9 years from now) | |
Drugs and Companies using OLICERIDINE ingredient
Treatment: Management of acute pain by intravenous injection
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1MG/ML (1MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 2MG/2ML (1MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 30MG/30ML (1MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.